Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003331:Coronary Vessels / Q000473:pathology; D004176:Dipyridamole / Q000627:therapeutic use; D004311:Double-Blind Method; D004727:Endothelium / Q000473:pathology; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011446:Prospective Studies; D011897:Random Allocation; D013927:Thrombosis / Q000517:prevention & control; D014680:Veins / Q000473:pathology / Q000637:transplantation
D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin